GenMAS: An Artificial Intelligence-Driven Pharmacokinetics Modelling and Assessment Strategy Incorporating ADMET and PBPK
Our Group: Yaxin Guβ , Peng Qiβ , Lingling Ma, Guodong Zhang*, Biao Lu, Fanglong Yang, Haizhou Zhang
Affiliation: Changchun Genescience Pharma
Last Update: June 2025
This project proposes GenMAS, a novel AI-driven modeling and assessment strategy aimed at advancing animal alternative in pharmacokinetics through the integration of ADMET property prediction and PBPK modeling.
We demonstrate the effectiveness of our method on case studies:
- [AI-ADMET prediction]: Validation on internal and external data sets.
- [AI-PBPK modeling]: Commercial software and self-built high-throughput PBPK model.
- Innovation: Combines machine learning-based ADMET prediction with commercial & high-throughput PBPK simulations
- Efficiency: Supports rapid parameter estimation and scalable model inference
- Scalability: Adaptable across species, endpoints, and drug types
We recommend using conda:
# Create and activate a virtual environment
conda create -n genmas_env python=3.8
conda activate genmas_env
# Install dependencies
numpy(1.24.3)
pandas(2.0.3)
scipy(1.10.1)
rdkit(2024.3.5)
scikit-learn(1.3.2)GenMAS/
βββ Data/ # Input datasets for three case studies
βββ Models/ # Machine learning and PBPK model implementations
βββ Scripts/ # Training, evaluation, and simulation scripts
βββ img/ # workflow fig
βββ README.md # Project description and instructions
ADMET models in the GenMAS are available inοΌhttps://figshare.com/articles/journal_contribution/ADMET_Models_of_GenMAS/29312867
python Scripts/ADMET_Model.py
python Scripts/ADMET_Predict.pySelf-built PBPK model is available at Models/
AI-PBPK screening pipeline is available at Scripts/GenMAS_AI-PBPK.md